This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Improved Estrogen Receptor Assessment by PET Using the Novel Radiotracer 18F-4FMFES in Estrogen Receptor-Positive Breast Cancer Patients: An Ongoing Phase II Clinical Trial
- 18F-Fluoroestradiol PET: Current Status and Potential Future Clinical Applications
- Imaging Diagnostic and Therapeutic Targets: Steroid Receptors in Breast Cancer
- International Union of Basic and Clinical Pharmacology. XCVII. G Protein-Coupled Estrogen Receptor and Its Pharmacologic Modulators
- In Vivo Imaging of Brain Estrogen Receptors in Rats: A 16{alpha}-18F-Fluoro-17{beta}-Estradiol PET Study
- Feasibility and Predictability of Perioperative PET and Estrogen Receptor Ligand in Patients with Invasive Breast Cancer
- Small-Animal PET of Steroid Hormone Receptors Predicts Tumor Response to Endocrine Therapy Using a Preclinical Model of Breast Cancer
- Novel insights on imaging sex hormone-dependent tumourigenesis in vivo
- Functional Images Reflect Aggressiveness of Endometrial Carcinoma: Estrogen Receptor Expression Combined with 18F-FDG PET
- Imaging Tumor Phenotype: 1 Plus 1 Is More Than 2
- Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET
- 7{alpha}-18F-Fluoromethyl-Dihydrotestosterone and 7{alpha}-18F-Fluoromethyl-Nortestosterone: Ligands to Determine the Role of Sex Hormone-Binding Globulin for Steroidal Radiopharmaceuticals
- Tumor Receptor Imaging
- Quantitative Imaging of Estrogen Receptor Expression in Breast Cancer with PET and 18F-Fluoroestradiol
- 18F-Fluoroacetate: A Potential Acetate Analog for Prostate Tumor Imaging--In Vivo Evaluation of 18F-Fluoroacetate Versus 11C-Acetate
- The Progress and Promise of Molecular Imaging Probes in Oncologic Drug Development
- Monitoring of Therapy in Androgen-Dependent Prostate Tumor Model by Measuring Tumor Proliferation
- [18F]Fluoroestradiol Radiation Dosimetry in Human PET Studies